Replimune (REPL) Other financing activities (2018 - 2026)
Replimune (REPL) reported Other financing activities of $92000.0 for Q1 2026, up 187.5% on a YoY basis from $32000.0 in Q1 2025, and down 88.37% sequentially from $791000.0 in Q4 2025.
Replimune (REPL) Other financing activities (2018 - 2026) Analysis & Trends
Replimune (REPL) has 9 years of Other financing activities data on file, last reported at $92000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other financing activities rose 187.5% year-over-year to $92000.0; the trailing twelve-month figure through Mar 2026 stood at $883000.0 (up 230.71% YoY), and the FY2026 full-year result was $883000.0, up 230.71% from the prior year.
- Other financing activities retreated to $92000.0 in Q1 2026, from $791000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $89.6 million in Q1 2023 to a low of -$48.3 million in Q4 2024.
- A 5-year average of $6.4 million and a median of $645500.0 in 2022 frame the typical range for Other financing activities.
- Peak annual rise in Other financing activities reached 3911.58% in 2024, while the deepest fall reached 2845.45% in 2024.
- Tracing REPL's Other financing activities over 5 years: stood at $500000.0 in 2022, then jumped by 251.6% to $1.8 million in 2023, then plunged by 2845.45% to -$48.3 million in 2024, then surged by 101.64% to $791000.0 in 2025, then plunged by 88.37% to $92000.0 in 2026.
- Business Quant data shows REPL's Other financing activities at $92000.0 in Q1 2026, $791000.0 in Q4 2025, and $32000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Replimune | 970.73 Mn | 970.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 92,000.00 |
| Mar 31, 2026 | 92,000.00 |
| Dec 31, 2025 | 791,000.00 |
| Dec 31, 2025 | 791,000.00 |
| Mar 31, 2025 | 32,000.00 |
| Mar 31, 2025 | 32,000.00 |
| Dec 31, 2024 | -48.27 Mn |
| Dec 31, 2024 | -48.27 Mn |
| Jun 30, 2024 | 48.50 Mn |
| Jun 30, 2024 | 48.50 Mn |
| Mar 31, 2024 | 1,000.00 |
| Mar 31, 2024 | 1,000.00 |
| Dec 31, 2023 | 1.76 Mn |
| Dec 31, 2023 | 1.76 Mn |
| Sep 30, 2023 | -1.21 Mn |
| Sep 30, 2023 | -1.21 Mn |
| Jun 30, 2023 | 1.21 Mn |
| Jun 30, 2023 | 1.21 Mn |
| Mar 31, 2023 | 89.61 Mn |
| Mar 31, 2023 | 89.61 Mn |